Current status of nucleic acid therapy and its new progress in cancer treatment
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113157 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Wenting Lou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medici…. Hauptthemen laut MEDLINE: Neoplasms, Nucleic Acids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Nucleic acid is an essential biopolymer in all living cells, performing the functions of storing and transmitting genetic information and synthesizing protein. In recent decades, with the progress of science and biotechnology and the continuous exploration of the functions performed by nucleic acid, more and more studies have confirmed that nucleic acid therapy for living organisms has great medical therapeutic potential. Nucleic acid drugs began to become independent therapeutic agents. As a new therapeutic method, nucleic acid therapy plays an important role in the treatment of genetic diseases, viral infections and cancers. There are currently 19 nucleic acid drugs approved by the Food and Drug Administration (FDA). In the following review, we start from principles and advantages of nucleic acid therapy, and briefly describe development history of nucleic acid drugs. And then we give examples of various RNA therapeutic drugs, including antisense oligonucleotides (ASO), mRNA vaccines, small interfering RNA (siRNA) and microRNA (miRNA), aptamers, and small activating RNA (saRNA). In addition, we also focused on the current status of nucleic acid drugs used in cancer therapy and the breakthrough in recent years. Clinical trials of nucleic acid drugs for cancer treatment are under way, conventional radiotherapy and chemotherapy combined with the immunotherapies such as checkpoint inhibitors and nucleic acid drugs may be the main prospects for successful cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China.
- Department of Surgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China; Department of Colorectal…
Zitieren
APA
Lou, W., Zhang, L., & Wang, J. (2024). Current status of nucleic acid therapy and its new progress in cancer treatment. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113157
Vancouver
Lou W, Zhang L, Wang J. Current status of nucleic acid therapy and its new progress in cancer treatment. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113157
BibTeX
@article{Lou2024,
author = {Lou, Wenting and Zhang, Leqi and Wang, Jianwei},
title = {Current status of nucleic acid therapy and its new progress in cancer treatment},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113157}
}
EUVIMED